Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03829319
Brief Title: Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

First Submitted : February 1, 2019
First Submitted that Met QC Criteria : February 1, 2019
First Posted : February 4, 2019

Last Update Submitted that Met QC Criteria : May 24, 2021
Last Update Posted : May 26, 2021